William John Gradishar
Impact in
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Cancer Cells and Metastasis
Papers in
- Cancer Research 125
- Breast Cancer Treatment Studies 105
- Cancer Genomics and Diagnostics 22
- Oncology 178
- Cancer Treatment and Pharmacology 76
- HER2/EGFR in Cancer Research 71
- Cancer survivorship and care 19
- Co-authors
- Paul Bhar (5 shared papers)Neil P. Desai (2 shared papers)Sergei Tjulandin (3 shared papers)Joyce A O'Shaughnessy (5 shared papers)Michael Hawkins (1 shared paper)Neville G. P. Davidson (1 shared paper)Heather S. Shaw (1 shared paper)Ricardo Costa (8 shared papers)
- Journals
- Journal of the National Comprehensive Cancer Network (36 papers)Breast Cancer Research and Treatment (23 papers)Journal of Clinical Oncology (21 papers)Clinical Breast Cancer (16 papers)Clinical Cancer Research (14 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
William John Gradishar
324 papers receiving 22.2k citations
William John Gradishar's Hit Papers
Peers
Comparison fields: 5 of 170
- Cancer Research 5.9k
- Oncology 10.2k
- Pulmonary and Respiratory Medicine 4.0k
- Biomaterials 1.2k
- Radiology, Nuclear Medicine and Imaging 1.5k
Countries citing papers authored by William John Gradishar
This map shows the geographic impact of William John Gradishar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William John Gradishar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William John Gradishar more than expected).
Fields of papers citing papers by William John Gradishar
This network shows the impact of papers produced by William John Gradishar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William John Gradishar. The network helps show where William John Gradishar may publish in the future.
Co-authors
The 25 scholars most cited alongside William John Gradishar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 330 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer Hit paper breakdown → | 2005 | 1796 |
| 2 | Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2020 | 1325 |
| 3 | Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 Hit paper breakdown → | 2003 | 1283 |
| 4 | Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer Hit paper breakdown → | 1991 | 1203 |
| 5 | Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2022 | 674 |
| 6 | 2006 | 612 | |
| 7 | Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial Hit paper breakdown → | 2020 | 482 |
| 8 | Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2018 | 460 |
| 9 | American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants Hit paper breakdown → | 2008 | 440 |
| 10 | NCCN Guidelines Insights: Breast Cancer, Version 1.2017 Hit paper breakdown → | 2017 | 431 |
| 11 | 2008 | 418 | |
| 12 | Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer Hit paper breakdown → | 2018 | 396 |
| 13 | 2009 | 369 | |
| 14 | 2018 | 353 | |
| 15 | NCCN Guidelines® Insights: Breast Cancer, Version 4.2023 Hit paper breakdown → | 2023 | 317 |
| 16 | Burnout and Career Satisfaction Among US Oncologists Hit paper breakdown → | 2014 | 303 |
| 17 | 2020 | 300 | |
| 18 | Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2024 | 298 |
| 19 | 2009 | 286 | |
| 20 | Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer Hit paper breakdown → | 2021 | 273 |
About William John Gradishar
William John Gradishar is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 330 papers that have together received 23.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (105 papers), Cancer Treatment and Pharmacology (76 papers), HER2/EGFR in Cancer Research (71 papers), Advanced Breast Cancer Therapies (58 papers), Estrogen and related hormone effects (34 papers), Cancer Genomics and Diagnostics (22 papers), Cancer survivorship and care (19 papers) and BRCA gene mutations in cancer (18 papers). The work is most often cited by research in Cancer Research (5.9k citations), Oncology (10.2k citations), Pulmonary and Respiratory Medicine (4.0k citations), Biomaterials (1.2k citations) and Radiology, Nuclear Medicine and Imaging (1.5k citations). William John Gradishar has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Paul Bhar, Neil P. Desai, Sergei Tjulandin, Joyce A O'Shaughnessy, Michael Hawkins, Neville G. P. Davidson, Heather S. Shaw, Ricardo Costa, Cesar Augusto Santa-Maria and Hyo Sook Han. Their work appears in journals such as Journal of the National Comprehensive Cancer Network, Breast Cancer Research and Treatment, Journal of Clinical Oncology, Clinical Breast Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.